Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of Jurkat T cells

Infection and Immunity

Volumn 67, Issue 12, 1999, Pages 6394-6402

  Gelfanova, Valentina ^a   Hansen, Eric J ^b   Spinola, Stanley M ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Emerson Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; HEMOLYSIN;

ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HAEMOPHILUS DUCREYI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

APOPTOSIS; BACTERIAL TOXINS; CELL LINE; FLOW CYTOMETRY; HAEMOPHILUS DUCREYI; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 0032722556     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Abeck, D., H. C. Korting, R. Zaba, Y. Dangor, G. Fehler, and R. C. Ballard. 1990. Soluble interleukin-2 receptors in serum and urine of patients with chancroid and their response to therapy. Int. J. Sex. Transm. Dis. AIDS 1:282-284.
2. Alfa, M. J., P. Degagne, and P. A. Totten. 1996. Haemophilus ducreyi hemolysin acts as a contact cytotoxin and damages human foreskin fibroblasts in cell culture. Infect. Immun. 64:2349-2352.
3. Al-Tawfiq, J. A., K. L. Palmer, C.-Y. Chen, J. C. Haley, B. P. Katz, A. F. Hood, and S. M. Spinola. 1999. Experimental infection of human volunteers with Haemophilus ducreyi does not confer protection against subsequent challenge. J. Infect. Dis. 179:1283-1287.
4. Al-Tawfiq, J. A., A. C. Thornton, B. P. Katz, K. R. Fortney, K. D. Todd, A. F. Hood, and S. M. Spinola. 1998. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J. Infect. Dis. 178:1684-1687.
5. Blackmore, C. A., K. Limpakarnjanarat, J. G. Rigau-Perez, W. L. Albritton, and J. R. Greenwood. 1985. An outbreak of chancroid in Orange County, California: descriptive epidemiology and disease-control measures. J. Infect. Dis. 151:840-844.
6. Brunham, R. C., and A. R. Ronald. 1991. Epidemiology of sexually transmitted diseases in developing countries, p. 61-80. In J. N. Wasserheit, S. O. Aral, K. K. Holmes, and P. J. Hitchcock (ed.), Research issues in human behavior and sexually transmitted diseases in the AIDS era. American Society for Microbiology, Washington, D.C.
7. 2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect. Immun. 65:5088-5095.
8. Cope, L. D., S. Lumbley, J. L. Latimer, J. Klesney-Tait, M. K. Stevens, L. S. Johnson, M. Purven, R. S. Munson, Jr., T. Lagergard, J. D. Radolf, and E. J. Hansen. 1997. A diffusible cytotoxin of Haemophilus ducreyi. Proc. Natl. Acad. Sci. USA 94:4056-4061.
9. Cope, L. D., R. Yogev, U. Muller-Eberhard, and E. J. Hansen. 1995. A gene cluster involved in the utilization of both free heme and heme:hemopexin by Haemophilus influenzae type b. J. Bacteriol. 177:2644-2653.
10. Cortes-Bratti, X., E. Chaves-Olarte, T. Lagergard, and M. Thelestam. 1999. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J. Clin. Investig. 103:107-115.
11. Darzynkiewicz, Z., S. Bruno, G. Del Bino, W. Gorczyca, M. A. Hotz, P. Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808.
12. Fleischer, B. 1988. Non-specific propagation of human antigen-dependent T lymphocyte clones. J. Immunol. Methods 109:215-219.
13. Gelfanova, V. P., K. R. Fortney, J. A. Al-Tawfiq, K. L. Palmer, and S. M. Spinola. 1999. Isolation of Haemophilus ducreyi-specific T cell lines from lesion of experimentally infected human subjects, abstr. B/D-251, p. 78. In Abstracts of the 99th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
14. Hammond, G. W., M. Slutchuk, J. Scatliff, E. Sherman, J. C. Wilt, and A. R. Ronald. 1980. Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. Rev. Infect. Dis. 2:867-879.
15. Hayes, R. J., K. F. Schulz, and F. A. Plummer. 1995. The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. J. Trop. Med. Hyg. 98:1-8.
16. Hiltke, T. J., M. E. Bauer, J. Klesney-Tait, E. J. Hansen, R. S. Munson, Jr., and S. M. Spinola. 1999. Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants. Microb. Pathog. 26:93-102.
17. Jessamine, P. G., and A. R. Ronald. 1990. Chancroid and the role of genital ulcer disease in the spread of human retrovirus. Med. Clin. N. Am. 74:1417-1431.
18. King, R., A. Gough, J. Nasio, F. Ndinya-Achola, F. Plummer, and J. Wilkins. 1996. An immunohistochemical analysis of naturally occurring chancroid. J. Infect. Dis. 174:427-430.
19. Kish, L. 1965. Survey sampling. John Wiley and Sons. Inc., New York, N.Y.
20. Kurita-Ochiai, T., and K. Ochiai. 1996. Immunosuppressive factor from Actinobacillus actinomycetemcomitans down regulates cytokine production. Infect. Immun. 64:50-54.
21. Lagergard, T. 1992. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid. Microb. Pathog. 13:203-217.
22. Lagergard, T., and M. Purven. 1993. Neutralizing antibodies to Haemophilus ducreyi cytotoxin. Infect. Immun. 61:1589-1592.
23. Lagergard, T., M. Purven, and A. Frisk. 1993. Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells. Microb. Pathog. 14:417-431.
24. Magro, C. M., A. N. Crowson, M. Alfa, A. Nath, A. Ronald, J. O. Ndinya-Achola, and J. Nasio. 1996. A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission. Hum. Pathol. 27:1066-1070.
25. Matzinger, P. 1991. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145:185-192.
26. Mayer, M. P. A., L. C. Bueno, E. J. Hansen, and J. M. Dirienzo. 1999. Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect. Immun. 67:1227-1237.
27. Morse, S. A. 1989. Chancroid and Haemophilus ducreyi. Clin. Microbiol. Rev. 2:137-157.
28. 2/M phase and apoptosis. Infect. Immun. 66:5980-5987.
29. Palmer, K. L., W. E. Goldman, and R. S. Munson, Jr. 1996. An isogenic hemolysin-deficient mutant of Haemophilus ducreyi lacks the ability to produce cytopathic effects on human foreskin fibroblasts. Mol. Microbiol. 21: 13-19.
30. Palmer, K. L., S. Grass, and R. S. Munson, Jr. 1994. Identification of a hemolytic activity elaborated by Haemophilus ducreyi. Infect. Immun. 62: 3041-3043.
31. Palmer, K. L., and R. S. Munson, Jr. 1995. Cloning and characterization of the genes encoding the haemolysin of Haemophilus ducreyi. Mol. Microbiol. 18:821-830.
32. Palmer, K. L., C. T. Schnizlein-Bick, A. Orazi, K. John, C.-Y. Chen, A. F. Hood, and S. M. Spinola. 1998. The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. J. Infect. Dis. 178:1688-1697.
33. Palmer, K. L., A. C. Thornton, K. R. Fortney, A. F. Hood, R. S. Munson, Jr. and S. M. Spinola. 1998. Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection. J. Infect. Dis. 178:191-199.
34. Peres, S. Y., O. Marches, F. Daigle, J.-P. Nougayrede, F. Herault, C. Tasca, J. DeRycke, and E. Oswald. 1997. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 24:1095-1107.
35. Pickett, C. L., E. C. Pesci, D. L. Cottle, G. Russell, A. N. Erdem, and H. Zeytin. 1996. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campvlobacter sp. cdtB genes. Infect. Immun. 64:2070-2078.
36. Purven, M., E. Falsen, and T. Lagergard. 1995. Cytotoxin production in 100 strains of Haemophilus ducreyi from different geographic locations. FEMS Microbiol. Lett. 129:221-224.
37. Purven, M., and T. Lagergard. 1992. Haemophilus ducreyi, a cytotoxin-producing bacterium. Infect. Immun. 60:1156-1162.
38. Purven, M., A. Frisk, I. Lonnroth, and T. Lagergard. 1997. Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody. Infect. Immun. 65:3496-3499.
39. Reid, S., R. Cross, and E. C. Snow. 1996. Combined Hoechst 33342 and merocyanine 540 staining to examine murine B cell cycle stage, viability and apoptosis. J. Immunol. Methods 192:43-54.
40. Scott, D. A., and J. B. Kaper. 1994. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect. Immun. 62:244-251.
41. Shenker, B. J., W. P. McArthur, and C. C. Tsai. 1982. Immune suppression induced by Actinobacillus actinomycetemcomitans. I. Effects on human peripheral blood lymphocyte responses to mitogens and antigens. J. Immunol. 128:148-154.
42. 2 arrest in human T cells. J. Immunol. 162:4773-4780.
43. Shenker, B. J., L. Vitale, and C. King. 1995. Induction of human T cells that coexpress CD4 and CD8 by an immunomodulatory protein produced by Actinobacillus actinomycetemcomitans. Cell. Immunol. 164:36-46.
44. Shenker, B. J., L. A. Vitale, and D. A. Welham. 1990. Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells. Infect. Immun. 58:3856-3862.
45. Simpson, D. L., P. Berthold, and N. S. Taichman. 1988. Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin. Infect. Immun. 56:1162-1166.
46. Spinola, S. M., G. E. Griffiths, J. A. Bogdan, and M. A. Menegus. 1992. Characterization of an 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi that contains a conserved surface-exposed epitope. Infect. Immun. 60:385-391.
47. Spinola, S. M., A. Orazi, J. N. Arno, K. Fortney, P. Kotylo, C.-Y. Chen, A. A. Campagnari, and A. F. Hood. 1996. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J. Infect. Dis. 173:394-402.
48. Spinola, S. M., L. M. Wild, M. A. Apicella, A. A. Gaspari, and A. A. Campagnari. 1994. Experimental human infection with Haemophilus ducreyi. J. Infect. Dis. 169:1146-1150.
49. Stevens, M. K., J. L. Latimer, S. R. Lumbley, C. K. Ward, L. D. Cope, T. Lagergard, and E. J. Hansen. 1999. Characterization of a Haemophilus ducreyi mutant deficient in the production of the cytolethal distending toxin. Infect. Immun. 67:3900-3908.
50. Sugai, M., T. Kawamoto, S. Y. Peres, Y. Ueno, H. Komatsuzawa, T. Fujiwara, H. Kurihara, H. Suginaka, and E. Oswald. 1998. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 66:5008-5019.
51. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1461.
52. Totten, P., D. Norn, and W. Stamm. 1995. Characterization of the hemolytic activity of Haemophilus ducreyi. Infect. Immun. 63:4409-4416.
53. Van Laer, L., J. Vingerhoets, G. Vanham, L. Kestens, J. Bwayo, J. Otido, P. Piot, and E. Roggen. 1995. In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyl antigens. Clin. Exp. Immunol. 102:243-250.
54. Wasserheit, J. N. 1992. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Transm. Dis. 19:61-77.
55. 2-phase cell cycle block. Infect. Immun. 64:1934-1940.